Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor GSK2118436 (GSK436)

K. L. Nathanson; A. Martin; R. Letrero; K. P. D'Andrea; S. O'Day; J. R. Infante; G. S. Falchook; M. Millward; C. M. Curtis; B. Ma; R. C. Gagnon; P. F. Lebowitz; G. V. Long; R. F. Kefford

doi:10.1200/jco.2011.29.15_suppl.8501

Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor GSK2118436 (GSK436)

K. L. Nathanson, A. Martin, R. Letrero, K. P. D'Andrea, S. O'Day, J. R. Infante, G. S. Falchook, M. Millward, C. M. Curtis, B. Ma, R. C. Gagnon, P. F. Lebowitz, G. V. Long, R. F. Kefford

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

27 Citations (Web of Science)

Original language	English
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	29
Issue number	15
DOIs	https://doi.org/10.1200/jco.2011.29.15_suppl.8501
Publication status	Published - 20 May 2011
Externally published	Yes

Access to Document

10.1200/jco.2011.29.15_suppl.8501

Cite this

Nathanson, K. L., Martin, A., Letrero, R., D'Andrea, K. P., O'Day, S., Infante, J. R., Falchook, G. S., Millward, M., Curtis, C. M., Ma, B., Gagnon, R. C., Lebowitz, P. F., Long, G. V., & Kefford, R. F. (2011). Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor GSK2118436 (GSK436). Journal of Clinical Oncology, 29(15). https://doi.org/10.1200/jco.2011.29.15_suppl.8501

@article{f8cdf98bc17d44ccbaa95525420cd088,

title = "Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor GSK2118436 (GSK436)",

author = "Nathanson, {K. L.} and A. Martin and R. Letrero and D'Andrea, {K. P.} and S. O'Day and Infante, {J. R.} and Falchook, {G. S.} and M. Millward and Curtis, {C. M.} and B. Ma and Gagnon, {R. C.} and Lebowitz, {P. F.} and Long, {G. V.} and Kefford, {R. F.}",

year = "2011",

month = may,

day = "20",

doi = "10.1200/jco.2011.29.15_suppl.8501",

language = "English",

volume = "29",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "15",

}

Nathanson, KL, Martin, A, Letrero, R, D'Andrea, KP, O'Day, S, Infante, JR, Falchook, GS, Millward, M, Curtis, CM, Ma, B, Gagnon, RC, Lebowitz, PF, Long, GV & Kefford, RF 2011, 'Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor GSK2118436 (GSK436)', Journal of Clinical Oncology, vol. 29, no. 15. https://doi.org/10.1200/jco.2011.29.15_suppl.8501

TY - JOUR

T1 - Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor GSK2118436 (GSK436)

AU - Nathanson, K. L.

AU - Martin, A.

AU - Letrero, R.

AU - D'Andrea, K. P.

AU - O'Day, S.

AU - Infante, J. R.

AU - Falchook, G. S.

AU - Millward, M.

AU - Curtis, C. M.

AU - Ma, B.

AU - Gagnon, R. C.

AU - Lebowitz, P. F.

AU - Long, G. V.

AU - Kefford, R. F.

PY - 2011/5/20

Y1 - 2011/5/20

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=uwapure5-25&SrcAuth=WosAPI&KeyUT=WOS:000208880302364&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1200/jco.2011.29.15_suppl.8501

DO - 10.1200/jco.2011.29.15_suppl.8501

M3 - Abstract/Meeting Abstract

SN - 0732-183X

VL - 29

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15

ER -

Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor GSK2118436 (GSK436)

Access to Document

Other files and links

Cite this